PWPS
ENTA icon

Pinnacle Wealth Planning Services’s Enanta Pharmaceuticals ENTA Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9K Hold
2,529
– – ﹤0.01% 1454
2025
Q4 		$39.9K Buy
+2,529
New +$32.1K ﹤0.01% 1363
2021
Q1 		– Sell
-662
Closed -$28K – 834
2020
Q4 		$28K Buy
+662
New +$29.1K 0.01% 1017

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pinnacle Wealth Planning Services's ENTA Position: Q1 2026 in Review

Pinnacle Wealth Planning Services held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 2,529 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Pinnacle Wealth Planning Services first reported a position in ENTA in Q4 2020 and has held it in 3 quarters since. The position peaked at $39.9K in Q4 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Pinnacle Wealth Planning Services held 2,529 shares of Enanta Pharmaceuticals worth $31.9K as of Q1 2026.
  • Pinnacle Wealth Planning Services left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #1454 holding.
  • Pinnacle Wealth Planning Services first reported a position in Enanta Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Enanta Pharmaceuticals position peaked at $39.9K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.